The Claim

A serum copeptin cutoff value greater than 3452 pg/mL is associated with poor glycemic control (HbA1c >7%) in adults with type 2 diabetes, with 90% sensitivity and 95% specificity, and a cutoff greater than 370 pg/mL is associated with diabetic kidney disease, with 95% sensitivity and 90% specificity.

Source: Copeptin as a dual biomarker in type 2 diabetes: association with glycemic control and diabetic kidney disease

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
44score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Description
1 study reviewed
In plain English

In adults with type 2 diabetes, a blood copeptin level above 3452 pg/mL indicates poor blood sugar control (HbA1c >7%), and a level above 370 pg/mL indicates diabetic kidney disease, based on measured sensitivity and specificity values.

See the scientific wording

A serum copeptin cutoff value greater than 3452 pg/mL identifies poor glycemic control (HbA1c >7%) in adults with type 2 diabetes with 90% sensitivity and 95% specificity, and a cutoff greater than 370 pg/mL identifies diabetic kidney disease with 95% sensitivity and 90% specificity, suggesting these thresholds may aid clinical risk stratification.

Why this might work

High blood sugar overstimulates the brain's stress sensors, causing the body to release too much of a hormone that tells the kidneys to hold onto water and constrict blood vessels. This increases pressure inside the kidney filters, damaging them over time and causing protein to leak into urine. At the same time, the excess hormone worsens insulin resistance and reduces insulin production, making blood sugar even harder to control.

Verified mechanismbased on 1 study

What the research says

1 study
  1. Study: Copeptin as a dual biomarker in type 2 diabetes: association with glycemic control and diabetic kidney disease

    This study found that a simple blood test for copeptin can accurately tell if someone with type 2 diabetes has bad blood sugar control or early kidney damage, using the exact cutoff numbers mentioned in the claim.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.